Buckingham Strategic Wealth’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | $523K | Buy |
32,169
+1,009
| +3% | +$16.4K | 0.01% | 457 |
|
|
2024
Q1 | $440K | Sell |
31,160
-2
| -0% | -$28 | ﹤0.01% | 499 |
|
|
2023
Q4 | $325K | Sell |
31,162
-52
| -0.2% | -$543 | ﹤0.01% | 552 |
|
|
2023
Q3 | $318K | Buy |
31,214
+52
| +0.2% | +$530 | ﹤0.01% | 513 |
|
|
2023
Q2 | $235K | Sell |
31,162
-48
| -0.2% | -$361 | ﹤0.01% | 589 |
|
|
2023
Q1 | $285K | Hold |
31,210
| – | – | 0.01% | 493 |
|
|
2022
Q4 | $285K | Sell |
31,210
-700
| -2% | -$6.38K | 0.01% | 495 |
|
|
2022
Q3 | $258K | Sell |
31,910
-239
| -0.7% | -$1.93K | 0.01% | 500 |
|
|
2022
Q2 | $242K | Buy |
32,149
+200
| +0.6% | +$1.51K | ﹤0.01% | 513 |
|
|
2022
Q1 | $300K | Buy |
31,949
+910
| +3% | +$8.55K | 0.01% | 473 |
|
|
2021
Q4 | $249K | Sell |
31,039
-906
| -3% | -$7.27K | ﹤0.01% | 520 |
|
|
2021
Q3 | $311K | Buy |
31,945
+746
| +2% | +$7.26K | 0.01% | 460 |
|
|
2021
Q2 | $309K | Buy |
31,199
+124
| +0.4% | +$1.23K | 0.01% | 459 |
|
|
2021
Q1 | $359K | Sell |
31,075
-25
| -0.1% | -$289 | 0.02% | 398 |
|
|
2020
Q4 | $300K | Hold |
31,100
| – | – | 0.02% | 419 |
|
|
2020
Q3 | $280K | Buy |
31,100
+11,000
| +55% | +$99K | 0.02% | 386 |
|
|
2020
Q2 | $248K | Sell |
20,100
-6,100
| -23% | -$75.3K | 0.02% | 349 |
|
|
2020
Q1 | $235K | Sell |
26,200
-263
| -1% | -$2.36K | 0.02% | 395 |
|
|
2019
Q4 | $259K | Sell |
26,463
-1,383
| -5% | -$13.5K | 0.02% | 388 |
|
|
2019
Q3 | $192K | Sell |
27,846
-608
| -2% | -$4.19K | 0.02% | 408 |
|
|
2019
Q2 | $263K | Buy |
28,454
+2,256
| +9% | +$20.9K | 0.03% | 364 |
|
|
2019
Q1 | $411K | Hold |
26,198
| – | – | 0.05% | 262 |
|
|
2018
Q4 | $404K | Buy |
26,198
+458
| +2% | +$7.06K | 0.06% | 219 |
|
|
2018
Q3 | $554K | Buy |
25,740
+17,442
| +210% | +$375K | 0.09% | 178 |
|
|
2018
Q2 | $202K | Buy |
+8,298
| New | +$202K | 0.03% | 343 |
|
|
2017
Q3 | – | Sell |
-17,820
| Closed | -$592K | – | 307 |
|
|
2017
Q2 | $592K | Buy |
+17,820
| New | +$592K | 0.14% | 138 |
|
|
2015
Q3 | – | Sell |
-4,408
| Closed | -$261K | – | 229 |
|
|
2015
Q2 | $261K | Buy |
+4,408
| New | +$261K | 0.09% | 175 |
|